URGO DEVELOPS ARTIFICIAL SKIN
The French pharmaceutical company Urgo has announced a world first: the laboratory-produced artificial skin designed for direct transplantation onto patients. Named Genesis, this project, launched in 2021, involves several scientific partners, including the CNRS (French National Centre for Scientific Research), the French Blood Establishment, and Dassault Systèmes. With a total investment of €100 million, including €22.8 million in public funding, this innovation aims to improve the treatment of severe burns by eliminating the need to harvest skin from other parts of the body. The first clinical trials are expected to begin soon.
© REPLAY NEWS — All rights reserved. Substantial reproduction requires permission.